Celestica Inc. (CLS) reported $18.23B of revenue for the twelve months ended Sep 30, 2026. That is up 61.6% from the year before. Revenue for fiscal 2025 was $12.39B.

Yes. Celestica Inc. earned $1.25B in net income for the twelve months ended Sep 30, 2026, a net margin of 6.8%.

How much cash and debt does CLS have?

Celestica Inc. reported $3.96B in cash and cash equivalents and $791.50M of debt on its most recent balance sheet in SEC filings.

How fast is CLS revenue growing?

Celestica Inc.'s revenue changed +28.5% in fiscal 2025, to $12.39B. Its compound annual growth rate was +16.6% over 5 years and +8.2% over 10 years.

What is CLS gross margin?

Celestica Inc.'s gross profit was $2.09B on $18.23B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 11.5%.

What is CLS free cash flow?

Celestica Inc. generated $545.40M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.41B less capital expenditures.

What is CLS earnings per share?

Diluted earnings per share were $10.55 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CLS last report financial results?

The latest statements here come from Celestica Inc.'s 10-Q filed on Oct 26, 2026, covering the period ended Sep 30, 2026.

Where does this CLS financial data come from?

Quantisnow builds these statements from the structured XBRL data Celestica Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · CLS

Celestica Inc. (CLS) financials

For the twelve months ended Sep 30, 2026, Celestica Inc. reported $18.23B of revenue and $1.25B of net income.

Revenue, TTM: $18.23B
Revenue growth, YoY: +61.6%
Net income, TTM: $1.25B
Net income growth, YoY: +73.8%
Net margin: 6.8%
Free cash flow, TTM: $545.40M
EPS, diluted, TTM: $10.55
EPS growth, YoY: +71.3%
Cash: $3.96B
Total debt: $791.50M
P/E: 20.92
P/S: 1.43
Market cap: $26.06B

Annual revenue$12.39B

FY2016FY2025

Annual net income$832.50M

FY2016FY2025

Annual free cash flow$458.30M

FY2016FY2025

CLS revenue and earnings growth

CLS revenueQ3 2026$5.83B

Quarter YoY: +82.5%
QoQ: +24.1%
FY YoY: +28.5%
5Y CAGR: +16.6%
10Y CAGR: +8.2%

CLS revenue was $5.83B in fiscal Q3 2026 (ended Sep 30, 2026), up 82.5% from a year earlier and up 24.1% from the prior quarter. For the full fiscal 2025 it was $12.39B, up 28.5% from fiscal 2024. Compound annual growth was +16.6% over 5 years and +8.2% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2025 is the highest of the 11 fiscal years on file.

CLS net incomeQ3 2026$397.20M

Quarter YoY: +48.3%
QoQ: +7.7%
FY YoY: +94.5%
5Y CAGR: +68.9%
10Y CAGR: +28.7%

CLS net income was $397.20M in fiscal Q3 2026 (ended Sep 30, 2026), up 48.3% from a year earlier and up 7.7% from the prior quarter. For the full fiscal 2025 it was $832.50M, up 94.5% from fiscal 2024. Compound annual growth was +68.9% over 5 years and +28.7% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 11 fiscal years on file.

CLS EPSQ3 2026$3.26

Quarter YoY: +41.1%
QoQ: +2.8%
FY YoY: +98.3%
5Y CAGR: +72.4%
10Y CAGR: +32.8%

CLS diluted EPS was $3.26 in fiscal Q3 2026 (ended Sep 30, 2026), up 41.1% from a year earlier and up 2.8% from the prior quarter. For the full fiscal 2025 it was $7.16, up 98.3% from fiscal 2024. Compound annual growth was +72.4% over 5 years and +32.8% over 10 years.

CLS free cash flowQ3 2026$115.60M

Quarter YoY: +30.0%
QoQ: -21.4%
FY YoY: +51.3%
5Y CAGR: +19.7%
10Y CAGR: +13.1%

CLS free cash flow was $115.60M in fiscal Q3 2026 (ended Sep 30, 2026), up 30.0% from a year earlier and down 21.4% from the prior quarter. For the full fiscal 2025 it was $458.30M, up 51.3% from fiscal 2024. Compound annual growth was +19.7% over 5 years and +13.1% over 10 years. It rose in 3 of the last 6 fiscal years. Fiscal 2025 is the highest of the 11 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$12.39B	$9.65B	$7.96B	$7.25B	$5.63B	$5.75B	$5.89B	$6.63B	$6.14B	$6.05B
Cost of revenue	$10.90B	$8.61B	$7.21B	$6.60B	$5.15B	$5.31B	$5.50B	$6.20B	$5.72B	$5.62B
Gross profit	$1.49B	$1.03B	$754.10M	$649.70M	$487.00M	$437.60M	$384.70M	$430.50M	$418.50M	$429.60M
Research and development	$118.20M	$78.00M	$60.90M	$46.30M	$38.40M	$29.90M	$28.40M	$28.80M	$26.20M	$24.90M
Selling, general and admin	$259.90M	$293.50M	$303.20M	$267.30M	$245.10M	$230.70M	$227.30M	$219.00M	$203.20M	$211.10M
Operating income	$1.04B	$599.30M	$338.30M	$289.30M	$167.70M	$127.90M	$149.30M	$106.30M	$143.20M	$158.70M
Interest expense	$52.60M	$52.10M	$78.90M	$51.70M	$31.70M	$37.70M	$49.50M	$24.40M	$10.10M	$10.00M
Pre-tax income	$983.20M	$532.20M	$306.00M	$239.10M	$136.00M	$90.20M	$99.80M	$81.90M	$133.10M	$163.00M
Income tax	$150.70M	$104.20M	$61.60M	$59.00M	$32.10M	$29.60M	$29.50M	-$17.00M	$27.60M	$24.70M
Net income	$832.50M	$428.00M	$244.40M	$180.10M	$103.90M	$60.60M	$70.30M	$98.90M	$105.50M	$138.30M
EPS, basic	$7.22	$3.62	$2.03	$1.46	$0.82	$0.47	$0.54	$0.71	$0.74	$0.98
EPS, diluted	$7.16	$3.61	$2.03	$1.46	$0.82	$0.47	$0.53	$0.70	$0.73	$0.96
Diluted shares	116.2M	118.7M	120.3M	123.6M	126.7M	129.1M	131.8M	140.6M	145.2M	143.9M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$595.60M	$423.30M	$370.40M	$374.50M	$394.00M	$463.80M	$479.50M	$422.00M	$515.20M	$557.20M
Inventory	$2.19B	$1.76B	$2.10B	$2.35B	$1.70B	$1.09B	$992.20M	$1.09B	$824.00M	$890.60M
Current assets	$5.67B	$4.51B	$4.51B	$4.33B	$3.44B	$2.74B	$2.59B	$2.82B	$2.48B	$2.35B
Goodwill	$333.10M	$340.50M	$321.70M	$321.80M	$324.20M	$198.60M	$198.30M	$198.40M	$23.20M	$23.20M
Total assets	$7.21B	$5.99B	$5.89B	$5.63B	$4.67B	$3.66B	$3.56B	$3.74B	$2.96B	$2.82B
Current liabilities	$3.94B	$3.02B	$3.22B	$3.06B	$2.25B	$1.58B	$1.48B	$1.62B	$1.27B	$1.25B
Long-term debt	$750.50M	$770.20M	$648.30M	-	-	-	-	-	-	-
Total debt	$750.50M	$770.20M	$648.30M	-	$0	$0	$0	$159.00M	-	-
Total liabilities	$5.00B	$4.09B	$4.12B	$3.95B	$3.20B	$2.26B	$2.20B	$2.41B	$1.59B	$1.58B
Shareholders' equity	$2.22B	$1.90B	$1.77B	$1.68B	$1.46B	$1.41B	$1.36B	$1.33B	$1.37B	$1.26B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$659.50M	$473.90M	$326.20M	$211.10M	$226.80M	$239.60M	$345.00M	$33.10M	$127.00M	$173.30M
Capital expenditures	$201.20M	$170.90M	$125.10M	$109.00M	$52.20M	$52.80M	$80.50M	$82.20M	$102.60M	$64.10M
Free cash flow	$458.30M	$303.00M	$201.10M	$102.10M	$174.60M	$186.80M	$264.50M	-$49.10M	$24.40M	$109.20M
Investing cash flow	-$203.70M	-$212.50M	-$122.40M	-$108.90M	-$364.30M	-$51.00M	$38.70M	-$545.60M	-$89.30M	-$64.00M
Financing cash flow	-$283.50M	-$208.50M	-$207.90M	-$121.70M	$67.70M	-$204.30M	-$326.20M	$419.30M	-$79.70M	-$97.40M
Share repurchases	$153.40M	$152.00M	$35.60M	$34.60M	-	-	-	-	-	-
Stock-based compensation	$69.80M	$57.40M	$55.60M	$51.00M	$33.40M	$25.80M	$34.10M	$33.40M	$30.10M	$33.00M
Depreciation and amortization	$175.70M	$151.90M	$130.80M	$115.90M	$126.30M	$124.70M	$135.40M	$89.10M	$76.50M	$75.60M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	28.5%	21.2%	9.8%	28.7%	-2.0%	-2.4%	-11.2%	8.0%	1.6%	7.2%
Net income growth, YoY	94.5%	75.1%	35.7%	73.3%	71.5%	-13.8%	-28.9%	-6.3%	-23.7%	106.7%
EPS growth, YoY	98.3%	77.8%	39.0%	78.0%	74.5%	-11.3%	-24.3%	-4.1%	-24.0%	128.6%
Gross margin	12.1%	10.7%	9.5%	9.0%	8.6%	7.6%	6.5%	6.5%	6.8%	7.1%
Operating margin	8.4%	6.2%	4.2%	4.0%	3.0%	2.2%	2.5%	1.6%	2.3%	2.6%
Net margin	6.7%	4.4%	3.1%	2.5%	1.8%	1.1%	1.2%	1.5%	1.7%	2.3%
Free cash flow margin	3.7%	3.1%	2.5%	1.4%	3.1%	3.2%	4.5%	-0.7%	0.4%	1.8%
Return on equity	37.6%	22.6%	13.8%	10.7%	7.1%	4.3%	5.2%	7.4%	7.7%	11.0%
Return on assets	11.5%	7.1%	4.1%	3.2%	2.2%	1.7%	2.0%	2.6%	3.6%	4.9%
Current ratio	1.44	1.49	1.40	1.42	1.52	1.73	1.75	1.74	1.96	1.88
Debt to equity	0.34	0.41	0.37	-	0.00	0.00	0.00	0.12	-	-

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
Revenue	$5.83B	$4.70B	$4.05B	$3.65B	$3.19B	$2.89B	$2.65B	$2.55B	$2.50B	$2.39B	$2.21B
Cost of revenue	$5.19B	$4.12B	$3.61B	$3.22B	$2.78B	$2.52B	$2.37B	$2.25B	$2.24B	$2.14B	$1.99B
Gross profit	$640.80M	$577.50M	$437.20M	$433.10M	$416.10M	$371.00M	$273.90M	$297.20M	$260.60M	$253.80M	$222.10M
Research and development	$51.20M	$46.30M	$41.20M	$30.20M	$36.40M	$34.00M	$17.60M	$23.40M	$18.70M	$19.40M	$16.50M
Selling, general and admin	$118.20M	$58.10M	$117.40M	$70.10M	$38.40M	$38.90M	$112.50M	$57.60M	$91.80M	$79.30M	$64.80M
Operating income	$460.00M	$458.30M	$272.10M	$314.40M	$325.00M	$272.50M	$128.80M	$202.60M	$138.00M	$132.90M	$125.80M
Interest expense	$24.10M	$21.20M	$16.00M	$9.40M	$13.80M	$14.40M	$13.70M	$11.90M	$11.20M	$15.00M	$14.00M
Pre-tax income	$455.80M	$441.60M	$256.30M	$301.30M	$310.90M	$257.30M	$113.70M	$189.50M	$124.00M	$113.50M	$105.20M
Income tax	$58.60M	$72.80M	$44.00M	$33.80M	$43.10M	$46.30M	$27.50M	$37.80M	$34.50M	$18.50M	$13.40M
Net income	$397.20M	$368.80M	$212.30M	$267.50M	$267.80M	$211.00M	$86.20M	$151.70M	$89.50M	$95.00M	$91.80M
EPS, basic	$3.30	$3.21	$1.85	$2.32	$2.33	$1.83	$0.74	$1.29	$0.76	$0.80	$0.77
EPS, diluted	$3.26	$3.17	$1.83	$2.29	$2.31	$1.82	$0.74	$1.29	$0.75	$0.80	$0.77
Diluted shares	121.8M	116.2M	115.7M	-	115.9M	115.9M	116.9M	-	118.9M	119.4M	119.3M

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
Cash and equivalents	$3.96B	$535.70M	$378.00M	$595.60M	$305.90M	$313.80M	$303.00M	$423.30M	$398.50M	$434.00M	$308.10M
Inventory	$4.51B	$3.40B	$2.67B	$2.19B	$2.05B	$1.92B	$1.79B	$1.76B	-	-	-
Current assets	$12.54B	$7.57B	$6.40B	$5.67B	$5.14B	$4.77B	$4.38B	$4.51B	-	-	-
Goodwill	$333.30M	$332.90M	$333.00M	$333.10M	$340.70M	$340.80M	$340.50M	$340.50M	-	-	-
Total assets	$15.14B	$9.79B	$8.26B	$7.21B	$6.61B	$6.24B	$5.83B	$5.99B	-	-	-
Current liabilities	$7.77B	$6.18B	$5.08B	$3.94B	$3.50B	$3.32B	$3.05B	$3.02B	-	-	-
Long-term debt	$791.50M	$784.00M	$746.50M	$750.50M	$756.70M	$848.60M	$915.00M	$770.20M	-	-	-
Total debt	$791.50M	$784.00M	$746.50M	$750.50M	$756.70M	$848.60M	$915.00M	$770.20M	-	-	-
Total liabilities	$8.92B	$7.31B	$6.16B	$5.00B	$4.58B	$4.48B	$4.28B	$4.09B	-	-	-
Shareholders' equity	$6.21B	$2.48B	$2.10B	$2.22B	$2.03B	$1.76B	$1.56B	$1.90B	$1.81B	$1.80B	$1.71B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
Operating cash flow	$389.70M	$410.90M	$356.30M	$250.60M	$126.20M	$152.40M	$130.30M	$143.40M	$122.80M	$99.60M	$108.10M
Capital expenditures	$274.10M	$263.80M	$229.50M	$94.70M	$37.30M	$32.50M	$36.70M	$47.60M	$46.00M	$36.90M	$40.40M
Free cash flow	$115.60M	$147.10M	$126.80M	$155.90M	$88.90M	$119.90M	$93.60M	$95.80M	$76.80M	$62.70M	$67.70M
Investing cash flow	-$262.20M	-$266.30M	-$218.40M	-$94.70M	-$37.30M	-$35.00M	-$36.70M	-$51.00M	-$51.00M	-$70.10M	-$40.40M
Financing cash flow	$3.30B	$13.10M	-$355.50M	$133.80M	-$96.80M	-$106.60M	-$213.90M	-$67.60M	-$107.30M	$96.40M	-$130.00M
Share repurchases	$0	$0	$22.60M	$35.70M	$0	$40.00M	$77.70M	$25.50M	$100.00M	$10.00M	$16.50M
Stock-based compensation	$21.30M	$19.30M	$30.50M	$13.00M	$15.60M	$15.20M	$26.00M	$10.10M	$12.70M	$11.90M	$22.70M
Depreciation and amortization	$48.50M	$44.00M	$39.60M	$52.70M	$40.30M	$45.30M	$37.40M	$40.00M	$39.30M	$36.90M	$35.70M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
Revenue growth, YoY	82.5%	62.4%	52.8%	43.6%	27.8%	21.0%	19.9%	-	-	-	-
Net income growth, YoY	48.3%	74.8%	146.3%	76.3%	199.2%	122.1%	-6.1%	-	-	-	-
EPS growth, YoY	41.1%	74.2%	147.3%	77.5%	208.0%	127.5%	-3.9%	-	-	-	-
Gross margin	11.0%	12.3%	10.8%	11.8%	13.0%	12.8%	10.3%	11.7%	10.4%	10.6%	10.1%
Operating margin	7.9%	9.8%	6.7%	8.6%	10.2%	9.4%	4.9%	8.0%	5.5%	5.6%	5.7%
Net margin	6.8%	7.8%	5.2%	7.3%	8.4%	7.3%	3.3%	6.0%	3.6%	4.0%	4.2%
Free cash flow margin	2.0%	3.1%	3.1%	4.3%	2.8%	4.1%	3.5%	3.8%	3.1%	2.6%	3.1%
Current ratio	1.61	1.23	1.26	1.44	1.47	1.44	1.43	1.49	-	-	-
Debt to equity	0.13	0.32	0.36	0.34	0.37	0.48	0.59	0.41	-	-	-

Source: XBRL data Celestica Inc. files with the SEC, latest filing dated Oct 26, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CLS peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CLS	$18.23B	+61.6%	$1.25B	6.8%	$26.06B
APHAmphenol Corporation	$33.05B	+57.6%	$5.93B	18.0%	$184.17B
TERTeradyne Inc.	$5.00B	+74.9%	$1.37B	27.5%	$34.07B
VLTOVeralto Corp	$5.80B	+6.4%	$1.00B	17.3%	$28.47B
FLEXFlex Ltd.	$30.95B	+17.5%	$1.04B	3.4%	$25.78B
JBLJabil Inc.	$35.95B	+20.6%	$1.04B	2.9%	$24.62B
HUBBHubbell Inc	$6.59B	+16.0%	$908.90M	13.8%	$22.69B
LFUSLittelfuse Inc.	$2.76B	+18.7%	$37.79M	1.4%	$9.04B
SANMSanmina Corporation	$12.76B	+58.6%	$308.13M	2.4%	$7.22B

CLS FAQ

9 questions

What is CLS revenue?
Celestica Inc. (CLS) reported $18.23B of revenue for the twelve months ended Sep 30, 2026. That is up 61.6% from the year before. Revenue for fiscal 2025 was $12.39B.
Is CLS profitable?
Yes. Celestica Inc. earned $1.25B in net income for the twelve months ended Sep 30, 2026, a net margin of 6.8%.
How much cash and debt does CLS have?
Celestica Inc. reported $3.96B in cash and cash equivalents and $791.50M of debt on its most recent balance sheet in SEC filings.
How fast is CLS revenue growing?
Celestica Inc.'s revenue changed +28.5% in fiscal 2025, to $12.39B. Its compound annual growth rate was +16.6% over 5 years and +8.2% over 10 years.
What is CLS gross margin?
Celestica Inc.'s gross profit was $2.09B on $18.23B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 11.5%.
What is CLS free cash flow?
Celestica Inc. generated $545.40M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.41B less capital expenditures.
What is CLS earnings per share?
Diluted earnings per share were $10.55 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CLS last report financial results?
The latest statements here come from Celestica Inc.'s 10-Q filed on Oct 26, 2026, covering the period ended Sep 30, 2026.
Where does this CLS financial data come from?
Quantisnow builds these statements from the structured XBRL data Celestica Inc. files with the SEC. It is provided for information only and is not investment advice.